0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover97.17%IV-35.44%PremiumMay 16, 2025Expiry Date5.49Intrinsic Value100Multiplier21DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9762Delta0.0153Gamma2.79Leverage Ratio-0.0057Theta0.0057Rho2.72Eff Leverage0.0021Vega
Denali Therapeutics Stock Discussion
Clinical Trial Success: Denali's Hunter Syndrome Drug Delivers Game-Changing Patient Improvements
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$